US Broker Ratings

Teleflex Incorporated (TFX) Stock Analysis: Exploring a 24% Potential Upside

Teleflex Incorporated (NYSE: TFX), a key player in the healthcare sector, specializes in the development and supply of single-use medical devices. Headquartered in Wayne, Pennsylvania, Teleflex..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a Promising 17.93% Potential Upside in the Biotechnology Sector

Roivant Sciences Ltd. (NASDAQ: ROIV), a United Kingdom-based biotechnology firm, is making waves in the healthcare sector with its innovative approach to drug discovery and development...

Ascendis Pharma A/S (ASND) Stock Analysis: A Promising 25% Upside Potential with Strong Buy Ratings

Investors with a keen eye on the biopharmaceutical sector should take a closer look at Ascendis Pharma A/S (NASDAQ: ASND), a Denmark-based biotechnology powerhouse with a..

Zoetis Inc. (ZTS) Stock Analysis: Growth Potential with a 30.60% Upside for Animal Health Leader

Zoetis Inc. (NYSE: ZTS), a dominant player in the animal healthcare sector, presents an intriguing opportunity for investors seeking growth in a robust market. With a..

Henry Schein, Inc. (HSIC) Investor Outlook: Unveiling an 18.81% Potential Upside Amidst Healthcare Sector Dynamics

For individual investors with an eye on the healthcare sector, Henry Schein, Inc. (HSIC) presents a compelling case. With a market capitalization of $8.9 billion, this..

The Ensign Group, Inc. (ENSG) Stock Analysis: Exploring Growth Potential with a 5.10% Upside

The Ensign Group, Inc. (NASDAQ: ENSG) stands out in the healthcare sector as a dynamic player in the medical care facilities industry. With a robust market..

Grifols, S.A. (GRFS) Stock Analysis: A Healthcare Giant with 42% Potential Upside

For investors seeking exposure to the healthcare sector’s dynamic landscape, Grifols, S.A. (NASDAQ: GRFS) presents an intriguing opportunity. The Spanish pharmaceutical powerhouse, with a market capitalization..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Unveiling an 80.87% Potential Upside

Summit Therapeutics Inc. (NASDAQ: SMMT) has captured the attention of investors with its promising growth potential in the biotechnology sector. With a market capitalization of $12.5..

Alcon Inc. (ALC) Stock Analysis: Exploring a 22% Potential Upside in the Vision Care Market

Alcon Inc. (NYSE: ALC), a global leader in eye care products, is garnering investor attention with its promising market position in the healthcare sector. Operating out..

Hologic, Inc. (HOLX) Stock Analysis: Navigating the Healthcare Landscape with Modest Upside Potential

Hologic, Inc. (NASDAQ: HOLX), a key player in the healthcare sector, stands at the forefront of women’s health diagnostics and medical imaging solutions. With a market..

Tenet Healthcare Corporation (THC) Stock Analysis: Exploring a 14.83% Potential Upside

Tenet Healthcare Corporation (NYSE: THC), a prominent player in the healthcare sector, has been drawing investor attention with a robust market capitalization of $20.01 billion. Operating..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Evaluating Growth Potential in the Healthcare Sector

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent player in the global healthcare industry, continues to capture investor attention with its expansive pharmaceutical operations spanning North..

Masimo Corporation (MASI) Stock Analysis: Navigating a 1.77% Potential Upside Amidst Robust Healthcare Innovations

Masimo Corporation (NASDAQ: MASI), a key player in the healthcare sector’s medical devices industry, is capturing investor attention with its innovative approach to patient monitoring technologies...

Incyte Corporation (INCY) Stock Analysis: Exploring a 16% Potential Upside with Robust Revenue Growth

Investors looking for promising opportunities in the healthcare sector may find Incyte Corporation (NASDAQ: INCY) a compelling choice. As a significant player in the biotechnology industry,..

GSK plc (GSK) Stock Analysis: Riding High on a 7.66% Potential Upside

GSK plc (NYSE: GSK), a stalwart in the healthcare sector, continues to attract investor attention with its substantial market presence and robust growth potential. As of..

Chemed Corp (CHE) Stock Analysis: Navigating Healthcare with a 10.23% Potential Upside

Chemed Corp (NYSE: CHE), a key player in the healthcare sector, specifically within the medical care facilities industry, presents a compelling case for investors looking to..

Madrigal Pharmaceuticals, Inc. (MDGL): Investor Outlook Highlights a Robust 50% Potential Upside

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has captured investor attention with its strong focus on developing therapeutics for metabolic dysfunction-associated steatohepatitis (MASH). With a market capitalization of..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Navigating a 44% Potential Upside in the Biotech Sector

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a prominent player in the biotechnology sector, has captured investor attention with its robust pipeline of innovative therapies aimed at tackling..

Exact Sciences Corporation (EXAS) Stock Analysis: Navigating the Diagnostic Leader’s Growth Path

Exact Sciences Corporation (NASDAQ: EXAS) stands at the forefront of the healthcare diagnostics sector, boasting a market capitalization of $19.77 billion. The company’s innovative approach to..

Exelixis, Inc. (EXEL) Stock Analysis: Navigating Growth in the Biotech Sector with a 13.56% Potential Upside

Exelixis, Inc. (NASDAQ: EXEL) has carved a notable niche in the biotechnology sector, focusing on developing therapies for some of the most challenging cancers. With a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds